314 related articles for article (PubMed ID: 11175262)
1. Regulation of Bcl-2-family proteins in myeloma cells by three myeloma survival factors: interleukin-6, interferon-alpha and insulin-like growth factor 1.
Jourdan M; De Vos J; Mechti N; Klein B
Cell Death Differ; 2000 Dec; 7(12):1244-52. PubMed ID: 11175262
[TBL] [Abstract][Full Text] [Related]
2. A major role for Mcl-1 antiapoptotic protein in the IL-6-induced survival of human myeloma cells.
Jourdan M; Veyrune JL; De Vos J; Redal N; Couderc G; Klein B
Oncogene; 2003 May; 22(19):2950-9. PubMed ID: 12771946
[TBL] [Abstract][Full Text] [Related]
3. Delineation of the roles of paracrine and autocrine interleukin-6 (IL-6) in myeloma cell lines in survival versus cell cycle. A possible model for the cooperation of myeloma cell growth factors.
Jourdan M; Mahtouk K; Veyrune JL; Couderc G; Fiol G; Redal N; Duperray C; De Vos J; Klein B
Eur Cytokine Netw; 2005; 16(1):57-64. PubMed ID: 15809207
[TBL] [Abstract][Full Text] [Related]
4. Prevention of myeloma cell apoptosis by ectopic bcl-2 expression or interleukin 6-mediated up-regulation of bcl-xL.
Schwarze MM; Hawley RG
Cancer Res; 1995 Jun; 55(11):2262-5. PubMed ID: 7757973
[TBL] [Abstract][Full Text] [Related]
5. Interferon alpha induces cell death through interference with interleukin 6 signaling and inhibition of STAT3 activity.
Thyrell L; Arulampalam V; Hjortsberg L; Farnebo M; Grandér D; Pokrovskaja Tamm K
Exp Cell Res; 2007 Nov; 313(19):4015-24. PubMed ID: 17880940
[TBL] [Abstract][Full Text] [Related]
6. IL-6 inhibits apoptosis of human myeloma cell line XG-7 through activation of JAK/STAT pathway and up-regulation of Mcl-1.
Song L; Li Y; Sun YX; Yu M; Shen BF
Ai Zheng; 2002 Feb; 21(2):113-6. PubMed ID: 12479056
[TBL] [Abstract][Full Text] [Related]
7. Atypical expression of ErbB3 in myeloma cells: cross-talk between ErbB3 and the interferon-alpha signaling complex.
Walters DK; French JD; Arendt BK; Jelinek DF
Oncogene; 2003 Jun; 22(23):3598-607. PubMed ID: 12789268
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-6 is responsible for drug resistance and anti-apoptotic effects in prostatic cancer cells.
Pu YS; Hour TC; Chuang SE; Cheng AL; Lai MK; Kuo ML
Prostate; 2004 Jul; 60(2):120-9. PubMed ID: 15162378
[TBL] [Abstract][Full Text] [Related]
9. Cytokines prevent dexamethasone-induced apoptosis via the activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase pathways in a new multiple myeloma cell line.
Ogawa M; Nishiura T; Oritani K; Yoshida H; Yoshimura M; Okajima Y; Ishikawa J; Hashimoto K; Matsumura I; Tomiyama Y; Matsuzawa Y
Cancer Res; 2000 Aug; 60(15):4262-9. PubMed ID: 10945640
[TBL] [Abstract][Full Text] [Related]
10. The cyclin-dependent kinase inhibitor flavopiridol induces apoptosis in multiple myeloma cells through transcriptional repression and down-regulation of Mcl-1.
Gojo I; Zhang B; Fenton RG
Clin Cancer Res; 2002 Nov; 8(11):3527-38. PubMed ID: 12429644
[TBL] [Abstract][Full Text] [Related]
11. Aberrant Stat3 signaling by interleukin-4 in malignant glioma cells: involvement of IL-13Ralpha2.
Rahaman SO; Vogelbaum MA; Haque SJ
Cancer Res; 2005 Apr; 65(7):2956-63. PubMed ID: 15805299
[TBL] [Abstract][Full Text] [Related]
12. Activation of sphingosine kinase mediates suppressive effect of interleukin-6 on human multiple myeloma cell apoptosis.
Li QF; Wu CT; Duan HF; Sun HY; Wang H; Lu ZZ; Zhang QW; Liu HJ; Wang LS
Br J Haematol; 2007 Sep; 138(5):632-9. PubMed ID: 17686057
[TBL] [Abstract][Full Text] [Related]
13. IL-4 and insulin-like growth factor-I inhibit the decline in Bcl-2 and promote the survival of IL-3-deprived myeloid progenitors.
Minshall C; Arkins S; Straza J; Conners J; Dantzer R; Freund GG; Kelley KW
J Immunol; 1997 Aug; 159(3):1225-32. PubMed ID: 9233617
[TBL] [Abstract][Full Text] [Related]
14. Distinct IL-6 signal transduction leads to growth arrest and death in B cells or growth promotion and cell survival in myeloma cells.
Cheung WC; Van Ness B
Leukemia; 2002 Jun; 16(6):1182-8. PubMed ID: 12040451
[TBL] [Abstract][Full Text] [Related]
15. IL-6-independent expression of Mcl-1 in human multiple myeloma.
Zhang B; Potyagaylo V; Fenton RG
Oncogene; 2003 Mar; 22(12):1848-59. PubMed ID: 12660820
[TBL] [Abstract][Full Text] [Related]
16. The survival of IL-6-dependent myeloma cells critically relies on their capability to transit the G1 to S phase interval of the cell cycle.
Côté S; Lemieux R; Simard C
Cell Signal; 2005 May; 17(5):615-24. PubMed ID: 15683736
[TBL] [Abstract][Full Text] [Related]
17. Interferon alpha extends the survival of human myeloma cells through an upregulation of the Mcl-1 anti-apoptotic molecule.
Puthier D; Thabard W; Rapp M; Etrillard M; Harousseau J; Bataille R; Amiot M
Br J Haematol; 2001 Feb; 112(2):358-63. PubMed ID: 11167829
[TBL] [Abstract][Full Text] [Related]
18. IFN-alpha induces autocrine production of IL-6 in myeloma cell lines.
Jourdan M; Zhang XG; Portier M; Boiron JM; Bataille R; Klein B
J Immunol; 1991 Dec; 147(12):4402-7. PubMed ID: 1753108
[TBL] [Abstract][Full Text] [Related]
19. Mcl-1 mediates cytokine deprivation induced apoptosis of human myeloma cell line XG-7.
Song L; Li Y; Sun Y; Shen B
Chin Med J (Engl); 2002 Aug; 115(8):1241-3. PubMed ID: 12215301
[TBL] [Abstract][Full Text] [Related]
20. IFN-gamma upregulates anti-apoptotic gene expression and inhibits apoptosis in IL-3-dependent hematopoietic cells.
Sekiya M; Adachi M; Takayama S; Reed JC; Imai K
Biochem Biophys Res Commun; 1997 Oct; 239(2):401-6. PubMed ID: 9344841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]